Purple Sweet Potato Powder Containing Anthocyanin Mitigates High-Fat-Diet-Induced Dry Eye Disease.
Study Goal
The researchers aimed to determine whether purple sweet potato (PSP) powder could mitigate high-fat diet-induced dry eye disease (DED) by regulating oxidative stress and lipid homeostasis.
Results Summary
PSP treatment preserved lacrimal gland secretory function, prevented ocular surface erosion, reduced oxidative stress, and regulated lipid homeostasis, though it did not significantly reduce body weight or fat.
Population
Animal model (high-fat diet-induced DED)
Effective Dosage
5% PSP powder added to the diet
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Purple sweet potato (PSP) powder with anthocyanins | decrease | oxidative stress and inflammation | - | - | possesses the ability to reduce | #1 |
Purple sweet potato (PSP) powder | no change | body weight | animal model of high fat diet (HFD)-induced DED | - | could not significantly reduce | #2 |
Purple sweet potato (PSP) powder | no change | body fat | animal model of high fat diet (HFD)-induced DED | - | could not significantly reduce | #3 |
PSP treatment | increase | LG secretory function | animal model of high fat diet (HFD)-induced DED | - | ameliorated the effects of DED by preserving | #4 |
PSP treatment | decrease | ocular surface erosion | animal model of high fat diet (HFD)-induced DED | - | ameliorated the effects of DED by preventing | #5 |
PSP treatment | increase | LG structure | animal model of high fat diet (HFD)-induced DED | - | ameliorated the effects of DED by preserving | #6 |
PSP treatment | increase | superoxide dismutase levels | animal model of high fat diet (HFD)-induced DED | - | increased | #7 |
PSP treatment | decrease | hypoxia-inducible factor 1-α levels | animal model of high fat diet (HFD)-induced DED | - | reduced | #8 |
PSP treatment | decrease | oxidative stress | animal model of high fat diet (HFD)-induced DED | - | reduced | #9 |
PSP treatment | increase | ATP-binding cassette transporter 1 levels in LG tissue | animal model of high fat diet (HFD)-induced DED | - | increased | #10 |
PSP treatment | increase | acetyl-CoA carboxylase 1 levels in LG tissue | animal model of high fat diet (HFD)-induced DED | - | increased | #11 |
PSP treatment | neutral | lipid homeostasis maintenance | animal model of high fat diet (HFD)-induced DED | - | regulated | #12 |
PSP treatment | decrease | DED | animal model of high fat diet (HFD)-induced DED | - | reduced the effects of | #13 |
PSP treatment | neutral | oxidative stress and lipid homeostasis in the LG | animal model of high fat diet (HFD)-induced DED | - | ameliorated the effects of HFD-induced DED through the regulation of | #14 |
high fat diet (HFD) | neutral | structure of lacrimal gland (LG) tissue | animal model of high fat diet (HFD)-induced DED | - | altered | #15 |
high fat diet (HFD) | decrease | LG secretory function | animal model of high fat diet (HFD)-induced DED | - | reduced | #16 |
high fat diet (HFD) | decrease | proteins related to DED development, including α-smooth muscle actin and aquaporin-5 | animal model of high fat diet (HFD)-induced DED | - | eliminated the expression of | #17 |
Purple sweet potato (PSP) powder with anthocyanins possesses the ability to reduce oxidative stress and inflammation. Studies have presumed a positive correlation between body fat and dry eye disease (DED) in adults. The regulation of oxidative stress and inflammation has been proposed as the mechanism underlying DED. This study developed an animal model of high fat diet (HFD)-induced DED. We added 5% PSP powder to the HFD to evaluate the effects and underlying mechanisms in mitigating HFD-induced DED. A statin drug, atorvastatin, was also added to the diet separately to assess its effect. The HFD altered the structure of lacrimal gland (LG) tissue, reduced LG secretory function, and eliminated the expression of proteins related to DED development, including α-smooth muscle actin and aquaporin-5. Although PSP treatment could not significantly reduce body weight or body fat, it ameliorated the effects of DED by preserving LG secretory function, preventing ocular surface erosion, and preserving LG structure. PSP treatment increased superoxide dismutase levels but reduced hypoxia-inducible factor 1-α levels, indicating that PSP treatment reduced oxidative stress. PSP treatment increased ATP-binding cassette transporter 1 and acetyl-CoA carboxylase 1 levels in LG tissue, signifying that PSP treatment regulated lipid homeostasis maintenance to reduce the effects of DED. In conclusion, PSP treatment ameliorated the effects of HFD-induced DED through the regulation of oxidative stress and lipid homeostasis in the LG.